Biological Immunology

Ocrevus Zunovo

Payments companies reported to CMS as associated with Ocrevus Zunovo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$757Kassociated payments (2023-2025)
4,817clinicians with associated payments
2companies reporting

By year

2024 $83K
2025 $674K

Payments reported as associated with Ocrevus Zunovo, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $573K
Family $42K
Neuromuscular Medicine (Psychiatry & Neurology) $23K
Nurse Practitioner $21K
Physician Assistant $18K
Medical $7,437

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ocrevus Zunovo

These are the largest totals companies reported as associated with Ocrevus Zunovo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Amanda Hernandez-Jones Farmington, CT Neurology (Psychiatry & Neurology) $45,984.07
Mary Ann Picone Teaneck, NJ Neurology (Psychiatry & Neurology) $41,812.02
Faria Amjad Washington, DC Neurology (Psychiatry & Neurology) $32,639.76
Kyle Smoot Portland, OR Neurology (Psychiatry & Neurology) $29,718.56
Ann Bass San Antonio, TX Neurology (Psychiatry & Neurology) $27,639.59
Gabriel Pardo Oklahoma City, OK Neurology (Psychiatry & Neurology) $24,752.82
Marwa Kaisey West Hollywood, CA Neuromuscular Medicine (Psychiatry & Neurology) $21,398.23
Angela Applebee Albany, NY Neurology (Psychiatry & Neurology) $17,604.10
Aram Zabeti Cincinnati, OH Neurology (Psychiatry & Neurology) $16,259.22
Barry Singer Saint Louis, MO Neurology (Psychiatry & Neurology) $15,665.68

Prescribed Ocrevus Zunovo?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.